Abelson Helper Integration Site 1 (AHI1) Peptide
-
- Target See all AHI1 products
- AHI1 (Abelson Helper Integration Site 1 (AHI1))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- KDSTLRIMDL RILAARKFVG AANYREKIHS TLTPCGTLLF SGSEDGIVYV
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of Ahi1 antibody,
Alternative Names: Ahi1 control peptide, Ahi1 antibody Blocking Peptide, Anti-Ahi1 Blocking Peptide, Abelson helper integration site 1 Blocking Peptide, Ahi-1 Blocking Peptide, Ahi1 Blocking Peptide, Ahi1, Ahi-1, Ahi 1, Ahi-1 Blocking Peptide, Ahi 1 Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- AHI1 (Abelson Helper Integration Site 1 (AHI1))
- Synonyms
- AHI1 Peptide, AHI-1 Peptide, JBTS3 Peptide, ORF1 Peptide, dJ71N10.1 Peptide, 1700015F03Rik Peptide, Ahi-1 Peptide, D10Bwg0629e Peptide, Abelson helper integration site 1 Peptide, AHI1 Peptide, ahi1 Peptide, Ahi1 Peptide
- Background
- Mutations in the human homolog are associated with Joubert syndrome, an autosomal recessive disorder resulting in severe mental retardation.
- Molecular Weight
- 120 kDa
-